中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 3
Mar.  2023
Turn off MathJax
Article Contents

Value of different scoring models in predicting the survival of patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt

DOI: 10.3969/j.issn.1001-5256.2023.03.016
Research funding:

National Natural Science Foundation of China (82170594)

More Information
  • Corresponding author: CHEN Dongfeng, chendf1981@126.com (ORCID: 0000-0001-5514-7358)
  • Received Date: 2022-11-10
  • Accepted Date: 2022-12-29
  • Published Date: 2023-03-20
  •   Objective  To compare the value of Child-Pugh score, Model for End-Stage Liver Disease (MELD) score, MELD combined with serum sodium concentration (MELD-Na) score, CLIF Consortium Acute Decompensation (CLIF-C AD) score, and Freiburg index of post-transjugular intrahepatic portosystemic shunt (TIPS) survival (FIPS) score in predicting the survival of patients undergoing TIPS.  Methods  A retrospective analysis was performed for the clinical data of 447 patients with liver cirrhosis who underwent TIPS in several hospitals in southwest China, among whom there were 306 patients in the survival group and 62 in the death group. The scores of the above five models were calculated, and a survival analysis was performed based on these models. The independent samples t-test was used for comparison of normally distributed continuous data between groups, and the non-parametric Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the Pearson chi-square test was used for comparison of categorical data between groups; a multivariate Cox regression analysis was used for correction analysis of known influencing factors with statistical significance which were not included in the scoring models; the Kaplan-Meier method was used to evaluate the discriminatory ability of each model in identifying risks in the surgical population, and the log-rank test was used for analysis. The area under the receiver operating characteristic curve (AUC), C-index at different time points, and calibration curve were used to evaluate the predictive ability of each scoring model.  Results  Compared with the death group, the survival group had significantly lower age (Z=2.884, P < 0.05), higher albumin (t=3.577, P < 0.05), and Na+ (Z=-3.756, P < 0.05) and significantly lower proportion of patients with alcoholic cirrhosis (χ2=22.674, P < 0.05), aspartate aminotransferase (Z=2.141, P < 0.05), prothrombin time (Z=2.486, P < 0.05), international normalized ratio (Z=2.429, P < 0.05), total bilirubin (Z=3.754, P < 0.05), severity of ascites (χ2=14.186, P < 0.05), and scores of the five models (all P < 0.05). Survival analysis showed that all scoring models effectively stratified the prognostic risk of the patients undergoing TIPS. Comparison of the C-index of each scoring model at different time points showed that Child-Pugh score had the strongest ability in predicting postoperative survival, followed by MELD-Na score, MELD score, and CLIF-C AD score, and FIPS score had a relatively poor predictive ability; in addition, the prediction efficiency of each score gradually decreased over time. Child-Pugh score had the largest AUC of 0.832 in predicting 1-year survival rate after surgery, and MELD-Na score had the largest AUC of 0.726 in predicting 3-year survival rate after surgery, but FIPS score had a poor ability in predicting 1- and 3-year survival rates.  Conclusion  All five scoring models can predict the survival of patients with liver cirrhosis after TIPS and can provide effective stratification of prognostic risk for such patients. Child-Pugh score has a better ability in predicting short-term survival, while MELD-Na score has a better ability in predicting long-term survival, but FIPS score has a relatively poor predictive ability in predicting both short-term and long-term survival.

     

  • loading
  • [1]
    BOIKE JR, THORNBURG BG, ASRANI SK, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1636-1662.e36. DOI: 10.1016/j.cgh.2021.07.018.
    [2]
    Chinese College of Interventionalists. CCI clinical practice guidelines: management of TIPS for portal hypertension (2019 edition)[J]. J Clin Hepatol, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.

    中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.
    [3]
    LIU F, ZHAO JB, WANG JY, et al. Transjugular intrahepatic portosystemic shunt via jugular vein by using specialized covered stent: 2-year follow-up observation[J]. J Interv Radiol, 2021, 30: 888-892. DOI: 10.3969/j.issn.1008-794X.2021.09.007.
    [4]
    PUGH RN, MURRAY-LYON IM, DAWSON JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60: 646-649. DOI: 10.1002/bjs.1800600817.
    [5]
    MALINCHOC M, KAMATH PS, GORDON FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4): 864-871. DOI: 10.1053/he.2000.5852.
    [6]
    BIGGINS SW, KIM WR, TERRAULT NA, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660. DOI: 10.1053/j.gastro.2006.02.010.
    [7]
    JALAN R, PAVESI M, SALIBA F, et al. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure[J]. J Hepatol, 2015, 62(4): 831-840. DOI: 10.1016/j.jhep.2014.11.012.
    [8]
    BETTINGER D, STURM L, PFAFF L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival[J]. J Hepatol, 2021, 74(6): 1362-1372. DOI: 10.1016/j.jhep.2021.01.023.
    [9]
    de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno Ⅶ - Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
    [10]
    COLAPINTO RF, STRONELL RD, BIRCH SJ, et al. Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter[J]. Can Med Assoc J, 1982, 126(3): 267-268.
    [11]
    GIANNINI E, BOTTA F, FUMAGALLI A, et al. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?[J]. Liver Int, 2004, 24(5): 465-470. DOI: 10.1111/j.1478-3231.2004.0949.x.
    [12]
    HUO TI, WANG YW, YANG YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis[J]. Liver Int, 2007, 27(4): 498-506. DOI: 10.1111/j.1478-3231.2007.01445.x.
    [13]
    RUBIN RA, HASKAL ZJ, O'BRIEN CB, et al. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE Ⅱ scores[J]. Am J Gastroenterol, 1995, 90(4): 556-563.
    [14]
    PARVINIAN A, SHAH KD, COUTURE PM, et al. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk[J]. J Vasc Interv Radiol, 2013, 24(7): 941-946. DOI: 10.1016/j.jvir.2013.03.018.
    [15]
    FENG IC, TZENG WS, WANG SJ, et al. The role of transjugular intrahepatic portosystemic shunt in acute variceal bleeding: differential survival owing to different cirrhosis etiology[J]. J Gastroenterol, 2010, 27: 166-174. DOI: 10.6557/GJT.201006_27(2)0.0001
    [16]
    SAAD N, RUDE MK, DARCY M, et al. Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt[J]. Ann Hepatol, 2016, 15(2): 215-221. DOI: 10.5604/16652681.1193716.
    [17]
    LI J, TANG S, ZHAO J, et al. Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic models[J]. Eur J Gastroenterol Hepatol, 2021, 33(12): 1547-1555. DOI: 10.1097/MEG.0000000000001890.
    [18]
    ASCHA M, ABUQAYYAS S, HANOUNEH I, et al. Predictors of mortality after transjugular portosystemic shunt[J]. World J Hepatol, 2016, 8(11): 520-529. DOI: 10.4254/wjh.v8.i11.520.
    [19]
    WEN L, HE S, ZHANG H, LUO X. Comparison study of five scoring systems for evaluating prognosis of patients undergoing transjugular intrahepatic portosystemic shunt procedures[J]. Chin J Hepatol, 2014, 22: 514-518. DOI: 10.3760/cma.j.issn.1007-3418.2014.07.008.

    文龙跃, 何松, 张浩, 等. 五种评分系统对经颈静脉肝内门体静脉分流术患者预后的评价比较[J]. 中华肝脏病杂志, 2014, 22: 514-518. DOI: 10.3760/cma.j.issn.1007-3418.2014.07.008.
    [20]
    SCHEPKE M, ROTH F, FIMMERS R, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting[J]. Am J Gastroenterol, 2003, 98(5): 1167-1174. DOI: 10.1111/j.1572-0241.2003.07515.x.
    [21]
    ANGERMAYR B, CEJNA M, KARNEL F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt[J]. Gut, 2003, 52(6): 879-885. DOI: 10.1136/gut.52.6.879.
    [22]
    YANG C, CHEN Q, ZHOU C, et al. FIPS score for prediction of survival after TIPS placement: External validation and comparison with traditional risk scores in a cohort of chinese patients with cirrhosis[J]. AJR Am J Roentgenol, 2022, 219(2): 255-267. DOI: 10.2214/AJR.21.27301.
    [23]
    LV Y, WANG Z, LI K, et al. Risk stratification based on chronic liver failure consortium acute decompensation score in patients with child-pugh B cirrhosis and acute variceal bleeding[J]. Hepatology, 2021, 73(4): 1478-1493. DOI: 10.1002/hep.31478.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(2)

    Article Metrics

    Article views (301) PDF downloads(101) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return